Tempus AI, Inc. recently announced a multi-year collaboration with Whitehawk Therapeutics, Inc. to utilize its real-world dataset in advancing biomarker-focused oncology research and optimizing ...

In the first nine months of 2025, Tempus AI Inc. TEM achieved several key regulatory milestones that strengthened its position in AI-driven diagnostics. In September 2025, the company received FDA 510 ...

Today the embargo has lifted on AMD's new Ryzen 3800XT and 3900XT processors. Almost identical to their non-XT counterparts, Luke dives deep into the behaviour of these two CPUs, looking at boost ...